D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Intellia Therapeutics
NTLA
$1.5B
| $230K | ﹤0.01% |
32,396
-1,187
| -4% | -$12K |
|
3752
Vital Farms
VITL
$558M
| $230K | ﹤0.01% |
7,541
-22,146
| -75% | -$797K |
|
3753
Corsair Gaming
CRSR
$1.05B
| $230K | ﹤0.01% |
25,933
-283,655
| -92% | -$2.8M |
|
3754
Invesco Water Resources ETF
PHO
$1.97B
| $229K | ﹤0.01% |
3,554
-400
| -10% | -$26.6K |
|
3755
Arcos Dorados Holdings
ARCO
$1.73B
| $228K | ﹤0.01% |
28,303
+6,050
| +27% | +$47.6K |
|
3756
Worthington Enterprises
WOR
$2.76B
| $228K | ﹤0.01% |
+4,545
| New | +$192K |
|
3757
VanEck Vietnam ETF
VNM
$491M
| $228K | ﹤0.01% |
18,263
-4,605
| -20% | -$54.6K |
|
3758
Global X FinTech ETF
FINX
$168M
| $226K | ﹤0.01% |
8,190
| – | – |
|
3759
Wynn Resorts
WYNN
$10.1B
| $225K | ﹤0.01% |
2,700
-41,597
| -94% | -$3.55M |
|
|
UHT
3760
Universal Health Realty Income Trust
UHT
$608M
| $225K | ﹤0.01% |
5,490
-6,225
| -53% | -$244K |
|
3761
Colony Bankcorp
CBAN
$462M
| $225K | ﹤0.01% |
13,907
-12,620
| -48% | -$207K |
|
3762
ALPS O'Shares US Small-Cap Quality Dividend ETF
OUSM
$885M
| $224K | ﹤0.01% |
+5,319
| New | +$231K |
|
3763
Twist Bioscience
TWST
$5.62B
| $223K | ﹤0.01% |
5,689
-101,579
| -95% | -$4.58M |
|
3764
MaxCyte
MXCT
$116M
| $223K | ﹤0.01% |
81,764
-26,837
| -25% | -$106K |
|
3765
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$693M
| $223K | ﹤0.01% |
5,484
| – | – |
|
3766
PUT
Analog Devices
ADI
$181B
| $222K | ﹤0.01% |
1,100
-88,200
| -99% | -$19.1M |
|
3767
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$741M
| $222K | ﹤0.01% |
7,455
-1,300
| -15% | -$39.4K |
|
3768
Prothena Corp
PRTA
$458M
| $220K | ﹤0.01% |
+17,803
| New | +$252K |
|
3769
CALL
Coeur Mining
CDE
$15.6B
| $220K | ﹤0.01% |
+37,200
| New | +$230K |
|
3770
CALL
Braze
BRZE
$2.45B
| $220K | ﹤0.01% |
+6,100
| New | +$245K |
|
|
BTX
3771
BlackRock Technology and Private Equity Term Trust
BTX
$957M
| $220K | ﹤0.01% |
35,139
| – | – |
|
3772
VictoryShares Free Cash Flow ETF
VFLO
$8.44B
| $220K | ﹤0.01% |
6,412
-19,596
| -75% | -$688K |
|
|
MAG
3773
DELISTED
MAG Silver
MAG
| $220K | ﹤0.01% |
14,392
+2,908
| +25% | +$45.1K |
|
3774
KT
KT
$8.84B
| $219K | ﹤0.01% |
+12,355
| New | +$213K |
|
3775
CALL
Aehr Test Systems
AEHR
$2.48B
| $219K | ﹤0.01% |
30,000
-32,900
| -52% | -$364K |
|
Similar funds
D.E. Shaw & Co's Q1 2025 Portfolio in Review
As of Q1 2025, D.E. Shaw & Co held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- D.E. Shaw & Co's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- D.E. Shaw & Co added most to GE Vernova in Q1 2025, an estimated $686M increase.
- D.E. Shaw & Co's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- D.E. Shaw & Co opened 569 new positions and closed 704 in Q1 2025.
- D.E. Shaw & Co's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.